LAS-R HUMAN COMPLEMENT CLQ TEST— 510(k) K780729

Name: FDA 510(k) clearance K780729
Creator: U.S. Food and Drug Administration
Published: 1978-05-18

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K780729 for LAS-R HUMAN COMPLEMENT CLQ TEST, Substantially Equivalent on 1978-05-18. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 2.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code DAK
Device class: Class 2
Regulation: 21 CFR 866.5240
Advisory panel: Immunology
Date received: 1978-05-02
Decision date: 1978-05-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DAK

view all

K031563 — BINDAZYME CLQ CIC EIA KIT2003-09-10
K032254 — IBL C1Q-CIC CIA TEST2003-08-29
K012576 — CIC-C1Q EIA2002-01-29
K973203 — THYMOSTAT ELISA FOR THE DETECTION OF HUMAN IGG,M AND A ANTI-RABBIT IGG ANTIBODIES1998-09-30
K972873 — IMMUSTRIP HAMA IGG1998-03-17

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.